Science1 publisher2 min readPublished
Single-dose gene therapy rebuilt retinal wiring in adult whippets with CaBP4 vision loss
Michigan State researchers say one dose of CaBP4 gene therapy improved whippets' vision and rebuilt retinal synapses, with gains lasting up to three years. It shows adult retinal wiring can still be remodelled, so far only in dogs.
The Scientist · Science desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction
What happened
- The team traced vision loss in a group of whippets to faulty CaBP4 and injected their retinas with a harmless virus carrying a working copy of the gene.
- Treated regions of the retina degraded less, and the outer plexiform layer, which holds key visual connections, expanded significantly.
- The study, published in Molecular Therapy Advances, comes out of a decade of research into these inherited eye conditions.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- capability If the canine result holds in people, adults with a CaBP4-type defect would still be candidates for structural repair, since the stunted layer expanded in adult dogs.
- constraint The evidence covers one rare gene in one breed and one retinal layer, so it cannot yet support claims about repairing adult nerve wiring damaged by injury or disease elsewhere.
- precedent The researchers suggest the approach could lead to methods for repairing other damaged neural networks; that claim now needs testing in a second tissue or a different cause of damage.
The treated whippets gained the most vision in dim light, the condition in which CaBP4 deficiency makes the most difference [9]. The CaBP4 protein handles calcium signalling, part of the chemical signalling the retina depends on [2][20]. When the gene is faulty, two structures fail to grow properly: the outer plexiform layer and the synaptic ribbons inside the light-sensing cells [12].
The structural findings are the unusual part of the study. "We were able to show three independent structural changes supporting plasticity in the adult retina," said Billie Beckwith-Cohen, a veterinary ophthalmologist at Michigan State University [26][6]. "Not only were new components added, but pre-existing abnormalities were repaired," Beckwith-Cohen said [7]. The paper describes "expansion of a layer that did not form normally during retinal development along with maturation of synaptic features such as ribbon elongation" [18]. It also reports a "nearly normal anatomical arrangement" in that layer [17].
ScienceAlert presents the work as raising the prospect of treatments that repair nerve cells in mammals, something it says many had thought impossible [5]. The researchers' own wording is narrower. They write that the outer plexiform layer "has profound plasticity" and that the ribbons "can mature and elongate following gene augmentation therapy well into adulthood" [22].
The thing this doesn't tell you is whether wiring damaged by injury or by later degeneration can be rebuilt the same way. The main defect in these dogs was a layer that did not form normally during development [18]. I think the evidence supports real adult plasticity in this part of the canine retina, with the condition that the damage began in development. Beckwith-Cohen's second sentence goes a step further than late development, because abnormalities already present were corrected [7]. ScienceAlert also reports evidence of nerve cells rewiring even after significantly stunted growth [25].
ScienceAlert's account does not give the number of dogs treated, their ages at injection, or how much the layer expanded beyond the word "significantly" [10]. Those are the first figures I would want. Before treatment the dogs had what the paper calls "severe electrophysiologic and synaptic dysfunction," and the researchers write that visual function was restored [21].
The human condition causes poor vision from childhood, and it is rare in both people and dogs [1][23]. Whether the approach works in humans has not been shown, though the team is confident it would translate, according to ScienceAlert [16]. Beckwith-Cohen compared the mutation to "a typo in a blueprint that makes the instructions incomprehensible to the system" [13]. "Our therapy essentially provides new instructions for the misspelled segment, like an editor," Beckwith-Cohen said [14].
What to watch
- Whether the full paper reports how many dogs were treated, their ages at injection, and how large the outer plexiform layer expansion was.
- Any move to test CaBP4 gene augmentation in people with the inherited condition.
- Studies asking whether the same synaptic remodelling appears in retinas damaged by later degeneration, beyond a layer that failed to form in development.